New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein

Details for Australian Patent Application No. 2010204552 (hide)

Owner Teva Pharmaceutical Industries Ltd.

Inventors Bock, Jason Benjamin; Bell, Adam Carr; Herpst, Jeffrey

Agent Davies Collison Cave

Pub. Number AU-A-2010204552

PCT Pub. Number WO2010/083439

Priority 61/145,436 16.01.09 US; 61/145,440 16.01.09 US

Filing date 15 January 2010

Wipo publication date 22 July 2010

International Classifications

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

4 August 2011 PCT application entered the National Phase

  PCT publication WO2010/083439 Priority application(s): WO2010/083439

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010204554-Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

2010204547-New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein